Emily A Sloan
Overview
Explore the profile of Emily A Sloan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
451
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yeh J, Marks J, Alzeer A, Sloan E, Varghese R, Paudel N, et al.
JTO Clin Res Rep
. 2022 Dec;
3(12):100428.
PMID: 36471683
Sotorasib is a inhibitor that recently received approval for use in locally advanced or metastatic -mutated NSCLC. CodeBreaK100, the phase 2 clinical trial leading to the approval of sotorasib, excluded...
2.
Gillon S, Junn J, Sloan E, Gupta N, Reddy A, Li Y
J Neurosurg Case Lessons
. 2022 Aug;
1(3):CASE2026.
PMID: 36034510
Background: Angiomatoid fibrous histiocytoma (AFH) is a rare, slowly progressive neoplasm that most commonly occurs in soft tissues. AFH rarely occurs in bone such as the calvaria. The authors present...
3.
Lucas C, Sloan E, Gupta R, Wu J, Pratt D, Vasudevan H, et al.
Acta Neuropathol
. 2022 Aug;
144(4):747-765.
PMID: 35945463
Gliomas arising in the setting of neurofibromatosis type 1 (NF1) are heterogeneous, occurring from childhood through adulthood, can be histologically low-grade or high-grade, and follow an indolent or aggressive clinical...
4.
Alonzo C, Burnsed J, Sloan E, Zanelli S
Neoreviews
. 2022 Jul;
23(8):e579-e581.
PMID: 35909106
No abstract available.
5.
Mehta A, Khan F, Wagner C, Hashemzadeh T, Stemer A, Sloan E, et al.
Neurohospitalist
. 2021 Dec;
12(1):162-166.
PMID: 34950407
This report explores the case of a 49-year-old African American male with a six-month history of multifocal neurological deficits who presented to an outside hospital after a generalized seizure. Patient...
6.
Sloan E, Gupta R, Koelsche C, Chiang J, Villanueva-Meyer J, Alexandrescu S, et al.
Brain Pathol
. 2021 Nov;
32(4):e13037.
PMID: 34821426
'Intracranial mesenchymal tumor, FET-CREB fusion-positive' occurs primarily in children and young adults and has previously been termed intracranial angiomatoid fibrous histiocytoma (AFH) or intracranial myxoid mesenchymal tumor (IMMT). Here we...
7.
Pekmezci M, Morshed R, Chunduru P, Pandian B, Young J, Villanueva-Meyer J, et al.
Sci Rep
. 2021 Jun;
11(1):12162.
PMID: 34108566
In the management of diffuse gliomas, the identification and removal of tumor at the infiltrative margin remains a central challenge. Prior work has demonstrated that fluorescence labeling tools and radiographic...
8.
Sloan E, Chiang J, Villanueva-Meyer J, Alexandrescu S, Eschbacher J, Wang W, et al.
Brain Pathol
. 2020 Nov;
31(4):e12918.
PMID: 33141488
Intracranial mesenchymal tumors with FET-CREB fusions are a recently described group of neoplasms in children and young adults characterized by fusion of a FET family gene (usually EWSR1, but rarely...
9.
Friedman L, Bullock T, Sloan E, Ring K, Mills A
Mod Pathol
. 2020 Oct;
34(3):627-636.
PMID: 33011747
Major histocompatibility complex (MHC) class I is a membrane-bound protein complex expressed on nucleated human cells. MHC class I presents intracellular protein fragments to cytotoxic T cells and triggers an...
10.
Ramani B, Gupta R, Wu J, Barreto J, Bollen A, Tihan T, et al.
Acta Neuropathol
. 2020 Sep;
140(6):907-917.
PMID: 32892244
Paragangliomas are neuroendocrine tumors of the autonomic nervous system that are variably clinically functional and have a potential for metastasis. Up to 40% occur in the setting of a hereditary...